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Background: As a substudy of the large, randomized LONG-DES-III and IV (Percuta-
neous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III and IV)
trials comparing sirolimus-eluting stents (SES), everolimus-eluting stents (EES) and
zotarolimus-eluting stents (ZES), we sought to investigate intimal hyperplasia (IH) and
vascular changes using volumetric intravascular ultrasound analysis
Methods: Complete angiographic and volumetric intravascular ultrasound data immedi-
ately after stenting and at 9-month follow-up were available in 259 patients with 259
lesions (130 SES, 61 EES and 68 ZES). External elastic membrane (EEM), stent, lumen,
and peristent plaque volumes (external elastic membrane minus stent) were normalized by
stent length.
Results: Normalized IH volume was greater in EES than SES (0.70.4 mm2 vs. 0.50.4
mm2, P 0.05), whereas normalized IH volume in ZES was similar to those in SES
(0.50.4 mm2 vs. 0.50.4 mm2). Change in normalized EEM volume was smaller in
EES than in SES (0.1 1.2 mm2 vs. 0.61.5 mm2, P0.05). However, the changes in
normalized EEM volume were not different between ZES vs. SES (0.61.5 mm2 vs. 0.6
1.1 mm2). Late stent malapposition was identified in 7 (5%) SES and 1 (1%) ZES, there
was no EES lesion with malapposition.
Conclusions: In the coronary lesions with long stent length, the degree of neointimal
growth in ZES was similar to SES, but less than that in EES. Expansive vascular
remodeling in ZES was comparable to SES, but greater than EES.
sirolimus
stent
zotarolimus
stent
everolimus
stent
N 130 68 61
stent length 41.1 14.1 42.7 13.2 45.9 14.9
Post stenting
Minimal stent area 5.5 1.6 5.7 1.5 5.5 1.5
Normalized stent volume 7.7 1.8 7.7 1.6 7.8 1.6
Normalized lumen volume 7.7 1.8 7.7 1.6 7.8 1.6
Normalized EEM volume 14.9 4.0 15.4 3.5 14.7 3.9
F/U
Minimal stent area 5.8 1.9 6.3 1.9 5.7 1.7
Minimal lesion area 5.2 1.7 5.4 1.4 4.9 1.6
Intimal hyperplasia volume 21.2 20.0 21.9 17.1 32.1 23.1‡
Normalized stent volume 7.9 2.0 8.2 1.7 7.9 1.7
Normalized EEM volume 15.5 4.1 16.4 3.5 14.9 3.8
normalized lumen volume 7.4 1.9 7.7 1.6 7.2 1.6
Normalized IH volume 0.5 0.4 0.5 0.4 0.7 0.4‡
Changes(f/u volume -
poststenting volume)
Normalized lumen
volume
-0.2 0.9 -0.2 0.7 -0.6 0.7‡
Normalized EEM volume 0.6 1.5 0.6 1.1 0..1 1.2
Late stent malapposition 7/130 (5%) 1/68 (0%) 0/61 (0%)
(‡ P 0.05)
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Background: Percutaneous coronary intervention carries a risk of dissections at the
edges of the implanted stent. Optical coherence tomography (OCT) enables detection and
detailed characterization of edge dissections (ED). We investigated the incidence,
predictors and outcome of OCT detected EDs.
Methods: All patients with OCT evaluation at baseline and 12-month follow-up (FU) in
the SORT-OUT V OCT substudy were included in the analysis. Plaques present in the
edge segments 5 mm proximal and distal to the study stent were characterized by plaque
type. All EDs were characterized by size and underlying plaque type.
Results: A total of 123 patients were included in the OCT substudy. Of these, 23 were
not available for analysis due to patient drop out, contraindication to the FU OCT or poor
image quality. No baseline EDs were found in three coronary event patients with no OCT
FU. One patient with stent thrombosis (ST) within 2 hours had ED in a fibroatheroma. In
the 97 patients included in the analysis 177 edges were visualized by OCT. A total of 37
(20.1%) EDs were detected in 33 patients (34% of patients). Size of EDs were
longitudinal length: 1.900.97 mm, transversal length: 1.120.61 mm, and distance from
tip of flap to vessel wall was 0.310.18 mm. Edge tissue characteristics for the analyzed
edges were fibrotic plaques 94 (53.1%), calcific plaques 11 (6.2%), 25 lipid plaques
(14.1%), and 47 (26.6%) edge segments with normal tissue. EDs occurred in fibrotic
plaques in 28 (15.8%), 6 (3.3%) in fibrocalcific plaques and 3 (1.7%) in lipid plaques.
None of the EDs were visible on XA. Two EDs were partially healed at 12 month FU, one
located in a residual stenosis after stenting. At FU the stenosis had progressed to clinical
significance.
Conclusions: Coronary EDs undetectable by XA were identified by OCT in 34% of the
study population and left untreated. One ED over a fibroatheroma may have caused acute
ST. All other EDs were completely or almost healed at 12 months FU. These results do
not support additional intervention when EDs in fibrotic or fibrocalcific plaques are
detected by OCT only.
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